TSX:CURAPharmaceuticals
Curaleaf (TSX:CURA) Valuation Check as U.S. Cannabis Rescheduling and Index Inclusion Shift Expectations
Regulatory Shift Puts Curaleaf in the Spotlight
Reports that President Trump may move to ease federal marijuana restrictions have pushed Curaleaf Holdings (TSX:CURA) into sharper focus, as investors reassess its prospects under a friendlier US regulatory regime.
See our latest analysis for Curaleaf Holdings.
The prospect of looser federal rules has lit a fire under Curaleaf, with a 1 month share price return of 76.47 percent and a year to date share price return of 121.74 percent. However,...